Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -
Please visit our MS learning channel on YouTube, which provides hundreds of MS videos presented by MS Experts across the USA, from many of our recorded education programs. Archived here: www.youtube.com/msviewsandnews -- Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram
Important Resources for the MS community are found on the left side of this blog.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Saturday, August 15, 2015
- Meditation for pain: “Mindfulness training” is a form of meditation aimed at reducing pain or emotional distress that occurs from health-related changes. Cecilia Wan (St. Michael’s Hospital, Toronto, ON) and colleagues tested whether a mindfulness-based meditation group – meeting once weekly for more than 2 hours – could reduce pain in 13 people with MS. Results showed a significant reduction in perceived pain and improvements in quality of life and mental health. Abstract QL20
- MS, something else, and pain: Kirsten M. Fiest (University of Manitoba, Winnipeg) and colleagues examined the relationship between comorbidities (conditions that occur alongside MS) and pain in 949 people with MS. Of the participants, 41.5% had at least one comorbid health condition, and 40.5% experienced disruptive pain. Pain was significantly increased in the presence of comorbidities that included fibromyalgia, rheumatoid arthritis, depression, and hypertension. Examining these associations may help to manage pain in MS. Abstract SX14
- Exercise at home: Rachel E. Klaren (University of Illinois at Urbana-Champaign) presented results from a Society-funded study in which 20 people with MS and mild disability were randomly assigned to a 12-week home cycling program or a control program involving stretching and muscle strengthening. Participants in both groups had weekly video chats with a behavioral coach. There were significantly greater improvements in cardiac function and mobility in the cycling group. Abstract RH02
- Exercise -- Phoning it in: Aaron P. Turner (University of Washington, Seattle) and colleagues compared the impact of a home exercise program that employed six telephone motivational sessions to a control program that consisted of exercise advice and a DVD. Participants receiving telephone counseling reported significantly increased physical activity, and reduced fatigue and depression compared to those in the control group. Abstract CP19
- Breathing better: Weakness and fatigue in respiratory muscles (that facilitate breathing) can lead to reduced exercise performance. Nadine M. Fisher (University at Buffalo) and team studied the effects of a six-week respiratory muscle training program in 29 people with MS and mild-to-moderate disability. The program improved respiratory muscle strength, exercise endurance, and participants’ perceptions of fatigue. Abstract RH06
- Shall we dance?: Alexander V. Ng (Marquette University, Milwaukee, WI) and colleagues are investigating whether an 8-week recreational ballroom dance program could improve physical function and quality of life in people with MS. One-hour sessions, twice a week, include rumba, foxtrot, waltz, swing, American tango, push-pull, and salsa. Participants are paired with a partner without MS. Preliminary results in 12 people indicated improved motor performance, gait, endurance, and cognition. Abstract QL13
AUGUST 12, 2015,
AXIM Biotechnologies, Inc., a biotechnology company focused on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products derived from industrial hemp, has announced commencement of clinical development of its leading patented pharmaceutical chewing gum, MedChew RX, for registration as a drug for relieving pain and/or spasticity in patients suffering from with multiple sclerosis (MS).
Many readers of MS News Today have reached out and urged us to do more to bring additional awareness about clinical trials applicable to the MS patient community. In response, we have created a new Clinical Trial Notification Program that helps us match individuals directly to relevant clinical trials based off of their profile information.
For participants in our clinical trial notification program, if your profile is a match, we may reach out directly to inform you of a clinical trial that might be specifically relevant to you.
What may work better than existing drugs to treat severe multiple sclerosis? Stem cells.
A recent research study focused on whether can benefit children with (MS). The article appeared in the August 12, 2015, online issue of , the medical journal of the American Academy of Neurology.
Friday, August 14, 2015
Exciting news! The first batch of our new MS Reporters videos are released this month.
So far, our MS reporters have taken your questions to experts in UK cities London and Edinburgh. And there are still more cities to come.
Check out our first release below.
Thursday, August 13, 2015
Nutra Pharma, a US-based biotechnology a company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, recently announced that it has filed an application with the US Food and Drug Administration (FDA) for orphan drug status for its investigational drug RPI-78M as a treatment for pediatric multiple sclerosis (MS).
Tuesday, August 11, 2015
CME Program: "Clinical Challenges in MS Care: Family Planning, Pregnancy, and Disease-Modifying Therapies"